Dr. Hans Friedrich Bünting - Net Worth and Insider Trading

Dr. Hans Friedrich Bünting Net Worth

The estimated net worth of Dr. Hans Friedrich Bünting is at least $0 dollars as of 2024-10-18. Dr. Hans Friedrich Bünting is the Supervisory Board of RWE AG and owns about 0 shares of RWE AG (XTER:RWE) stock worth over $0. Details can be seen in Dr. Hans Friedrich Bünting's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dr. Hans Friedrich Bünting has not made any transactions after 2024-09-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Dr. Hans Friedrich Bünting

Dr. Hans Friedrich Bünting Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dr. Hans Friedrich Bünting owns 1 companies in total, including RWE AG (XTER:RWE) .

Click here to see the complete history of Dr. Hans Friedrich Bünting’s form 4 insider trades.

Insider Ownership Summary of Dr. Hans Friedrich Bünting

Ticker	Comapny	Transaction Date	Type of Owner
XTER:RWE	RWE AG	2024-09-19	Supervisory Board

Dr. Hans Friedrich Bünting Latest Holdings Summary

Dr. Hans Friedrich Bünting currently owns a total of 1 stock. Dr. Hans Friedrich Bünting owns 0 shares of RWE AG (XTER:RWE) as of September 19, 2024, with a value of $0.

Latest Holdings of Dr. Hans Friedrich Bünting

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
XTER:RWE	RWE AG	2024-09-19	0	31.53	0

Holding Weightings of Dr. Hans Friedrich Bünting

Dr. Hans Friedrich Bünting Form 4 Trading Tracker

According to the SEC Form 4 filings, Dr. Hans Friedrich Bünting has made a total of 1 transactions in RWE AG (XTER:RWE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in RWE AG is the acquisition of 5,970 shares on September 19, 2024, which cost Dr. Hans Friedrich Bünting around $190,540.

Insider Trading History of Dr. Hans Friedrich Bünting

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dr. Hans Friedrich Bünting Trading Performance

GuruFocus tracks the stock performance after each of Dr. Hans Friedrich Bünting's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dr. Hans Friedrich Bünting is %. GuruFocus also compares Dr. Hans Friedrich Bünting's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dr. Hans Friedrich Bünting within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Dr. Hans Friedrich Bünting's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Dr. Hans Friedrich Bünting

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	1.68
Relative Return to S&P 500(%)	-0.09

Dr. Hans Friedrich Bünting Ownership Network

Ownership Network List of Dr. Hans Friedrich Bünting

No Data

Ownership Network Relation of Dr. Hans Friedrich Bünting

Dr. Hans Friedrich Bünting Owned Company Details

What does RWE AG do?

Who are the key executives at RWE AG?

Dr. Hans Friedrich Bünting is the Supervisory Board of RWE AG. Other key executives at RWE AG include Supervisory Board Dr. Frank Appel , Supervisory Board Mag. Dr. h.c. Monika Kircher , and Supervisory Board Ute Gerbaulet .

RWE AG (XTER:RWE) Insider Trades Summary

Over the past 18 months, Dr. Hans Friedrich Bünting made no insider transaction in RWE AG (XTER:RWE). Other recent insider transactions involving RWE AG (XTER:RWE) include a net purchase of 7,356 shares made by Zvezdana Seeger , a net purchase of 3,289 shares made by Ute Gerbaulet , and a net purchase of 30,000 shares made by Dr. Markus Krebber .

In summary, during the past 3 months, insiders sold 0 shares of RWE AG (XTER:RWE) in total and bought 18,024 shares, with a net purchase of 18,024 shares. During the past 18 months, 0 shares of RWE AG (XTER:RWE) were sold and 82,574 shares were bought by its insiders, resulting in a net purchase of 82,574 shares.

RWE AG (XTER:RWE)'s detailed insider trading history can be found in Insider Trading Tracker table.

RWE AG Insider Transactions

No Available Data

Dr. Hans Friedrich Bünting Mailing Address

Above is the net worth, insider trading, and ownership report for Dr. Hans Friedrich Bünting. Currently GuruFocus does not have mailing address information for Dr. Hans Friedrich Bünting.

Discussions on Dr. Hans Friedrich Bünting

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.